Tracking TECH? Get live short interest, options flow, and signals on ORTEX.Sign up free →

TECH

Bio-Techne Corporation

NASDAQ

Bio-Techne reports Q3 fiscal 2026 results today against a complicated backdrop: the stock has rebounded sharply but executives have been selling heavily into the rally, short interest has climbed to its highest level in months, and the Street is watching closely for any sign that tariff and NIH-funding headwinds are beginning to bite. The insider activity is the sharpest signal…

$56.68+3.54% 1d+5.92% 1w+6.68% 1mClose: 5 May 2026

Short interest % of float: 8.87%▲ 1.4%
Cost to borrow: 0.57%▲ 9.3%
Utilization: 26.4%
Put / call ratio: 5.56

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Snapshot as of 6 May 2026

Articles

Trader NoteTECH

Bio-Techne heads into earnings with insiders selling and shorts rebuilding

6 May 2026, 18:081 min read

Want the live picture for TECH?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TECH — free to start on ORTEX.